Previous 10 | Next 10 |
Researchers from the University of Southampton, United Kingdom and La Jolla Institute for Immunology (LJI) have identified a group of immune cells that may be responsible for severe asthma. Identified as cytotoxic CD4+ tissue-resident memory T cells , these cells congregate in the lungs ...
Scinai Immunotherapeutics (NASDAQ: SCNI) , a biopharmaceutical company focused on developing, manufacturing and commercializing innovative inflammation and immunology (“I&I”) biological products primarily for the treatment of autoimmune and infectious diseases, will be atte...
Showcasing Scinai’s end-to-end cGMP Biologics CDMO services at booth 271 Pursuing partnerships for Scinai’s pipeline of novel VHH antibody-based therapies JERUSALEM, Oct. 30, 2023 (GLOBE NEWSWIRE) -- via IBN -- Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI) today an...
Scinai will exhibit at the upcoming CPHI Barcelona event, showcasing its CDMO services The company expanded into the CDMO business earlier this year, operating under the banner Scinai Bioservices Scinai’s boutique end-to-end CDMO business division serves pharmaceutical, biotech, and al...
Proper and early treatment is crucial to preventing worse patient outcomes and limiting community transmission when infectious diseases such as influenza, measles, hepatitis A, B, and C, and the novel coronavirus are involved. However, infectious-disease treatment can become less effective due to...
Scinai announced positive results suggesting the therapeutic potential of its anti-IL-17 VHH antibodies (NanoAbs) in treating plaque psoriasis The preclinical study showed that the introduction of the NanoAbs downregulated the standard molecular markers S100A7, CXCL1, and CCL20, that are often ...
New research from the VA Portland Health Care System and Oregon Health & Sciences University has identified a biomarker that can potentially improve autoimmune disease treatment outcomes. The research team investigated ankylosing spondylitis (AS), an inflammatory disease that causes verte...
The coronavirus pandemic put a spotlight on the potential danger of infectious diseases and has helped spur research to develop faster and more efficient means of diagnosing infectious diseases. Early diagnosis of infectious diseases is critical to developing proper treatment and prevention pro...
Researchers have observed coronary microvascular dysfunction in a good number of patients with psoriasis. This is despite the fact that most of them hadn’t presented with any symptoms of cardiovascular illness. For their study, the researchers recruited 503 individuals who had been diagn...
Scinai Immunotherapeutics recently announced the closing of a registered direct offering, raising $1.33 million in gross proceeds The company intends to use the net proceed from the offering for, among others, research and development On its R&D agenda is the development and commercializa...
News, Short Squeeze, Breakout and More Instantly...
Scanner Technologies Corp Company Name:
SCNI Stock Symbol:
OTCMKTS Market:
Scanner Technologies Corp Website:
Scinai Immunotherapeutics (NASDAQ: SCNI) , a biotechnology company focused on developing inflammation and immunology (“I&I”) biological products and on providing contract development and manufacturing organization (“CDMO”) services through its Scinai Bioservic...
Scinai Immunotherapeutics Announces Positive Regulatory Feedback from the PEI on the path for Phase 1/2a in Plaque Psoriasis with its anti-IL-17 nanoAb PR Newswire Scinai Immunotherapeutics Announces Positive Regulatory Feedback from the Paul Erlich Institute (the PEI) for its...
A look at the top 10 most actives in the United States Conduit Pharmaceuticals Inc. (CDT) rose 40.0% to $0.3361 on volume of 63,970,490 shares Yoshitsu Co. Ltd (TKLF) rose 64.0% to $0.5024 on volume of 62,618,792 shares Silo Pharma Inc. (SILO) rose 91.8% to $2.0522 on volume of 59,055,593...